Related Experiment Video
Updated: Aug 8, 2025

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
Published on: September 22, 2011
κ-Opioid Receptors Improve Vascular Endothelial Dysfunction in Salt-Sensitive Hypertension via PI3K/Akt/eNOS
Qi Wu1, Hong Yang1, Qin Zheng2
1Department of Cardiovascular Medicine, The Second Affiliated Hospital of Chengdu Medical College, Chengdu, 610000 Sichuan, China.
Activation of kappa-opioid receptors (κ-OR) improves endothelial dysfunction in salt-sensitive hypertension by enhancing nitric oxide and reducing inflammation. This suggests κ-OR activation as a potential therapeutic strategy for hypertension.
Area of Science:
- Cardiovascular Pharmacology
- Endothelial Biology
- Hypertension Research
Background:
- Kappa-opioid receptors (κ-OR) play a role in cardiovascular regulation.
- Endothelial dysfunction is a key feature of salt-sensitive hypertension.
- The specific mechanisms of κ-OR in this context require further elucidation.
Purpose of the Study:
- To investigate the effects of κ-OR activation on endothelial dysfunction in a rat model of salt-sensitive hypertension.
- To elucidate the underlying molecular mechanisms, including the PI3K/Akt/eNOS pathway.
Main Methods:
- A rat model of salt-sensitive hypertension was established using a high-salt diet.
- Rats were treated with a κ-OR activator (U50,488H) or inhibitor (nor-BNI).
- Vascular function, oxidative stress markers, and protein expression (NOS, Akt, eNOS, Caveolin-1) were assessed in vivo and in vitro.
Main Results:
- κ-OR activation (U50,488H) improved vasodilation, increased nitric oxide (NO), and decreased inflammatory markers.
- U50,488H treatment reduced endothelial cell apoptosis and injury, and enhanced antioxidant capacity.
- Activation of the PI3K/Akt/eNOS pathway was observed, with increased p-Akt and p-eNOS expression.
Conclusions:
- κ-OR activation ameliorates vascular endothelial dysfunction in salt-sensitive hypertension.
- The protective effects are mediated through the PI3K/Akt/eNOS signaling pathway.
- κ-OR activation represents a promising therapeutic avenue for hypertension management.
Related Concept Videos
Hypertension II: Pathophysiology
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Endocrine Signaling

